�鶹Ů��

The Biden administration’s new biomedical research agency, the Advanced Research Projects Agency for Health, or ARPA-H, announced Tuesday that its first two hubs will land in the Dallas and Boston areas. The agency is using a “hub-and-spoke” model rather than centering all activity in one city. Part of the agency’s charter was that it would not be located in Washington, D.C., and members of Congress have spent years jockeying to bring the agency and subsequent STEM jobs to their districts. (Cohen, 9/26)

Dallas will be one of three national hubs for a new federal agency pursuing “game-changing breakthroughs” in science and medicine, the U.S. Department of Health and Human Services announced Tuesday. The Advanced Research Projects Agency for Health, or ARPA-H, is an effort by the Biden administration to prevent and treat diseases like cancer, Alzheimer’s disease and diabetes. Along with its other national hubs in Cambridge, Mass. and the Washington, D.C. area, ARPA-H will include a network of “spokes,” or local health institutions, across all 50 states. (Pandey, 9/26)

A new federal health research agency will set up shop in Cambridge with plans to spend billions of dollars to accelerate breakthroughs to vanquish tough-to cure diseases such as cancers and Alzheimer’s. The Advanced Research Projects Agency for Health, or ARPA-H, said Tuesday that Cambridge will host the agency’s “investor catalyst” hub, which will work with researchers, entrepreneurs, and financiers to speed the transition of basic research into new technologies and medicines. (Chesto and Weisman, 9/26)

The Biden administration announced almost $115 million in funding for three new cancer research programs Tuesday, as well as a nationwide network to deploy health innovation and medical breakthroughs to a wider swath of the country faster. The programs are through the Advanced Research Projects Agency for Health, the new agency focused on high-risk, high-reward research. (Schumaker, 9/26)